| 2we1 |
EBV dUTPase mutant Asp131Asn with bound dUMP |
1 |
1 |
X-RAY DIFFRACTION |
| 2we2 |
EBV dUTPase double mutant Gly78Asp-Asp131Ser with dUMP |
1 |
1 |
X-RAY DIFFRACTION |
| 2we3 |
EBV dUTPase inactive mutant deleted of motif V |
1 |
1 |
X-RAY DIFFRACTION |
| 2we4 |
Carbamate kinase from Enterococcus faecalis bound to a sulfate ion and two water molecules, which mimic the substrate carbamyl phosphate |
2 |
2 |
X-RAY DIFFRACTION |
| 2we5 |
Carbamate kinase from Enterococcus faecalis bound to MgADP |
2 |
2 |
X-RAY DIFFRACTION |
| 2we6 |
Crystal Structure of Plasmodium falciparum Ubiquitin Carboxyl- terminal Hydrolase 3 (UCHL3) |
2 |
2 |
X-RAY DIFFRACTION |
| 2we7 |
Crystal structure of Mycobacterium tuberculosis Rv0376c homologue from Mycobacterium smegmatis |
2 |
2 |
X-RAY DIFFRACTION |
| 2we8 |
Crystal structure of Mycobacterium tuberculosis Rv0376c homologue from Mycobacterium smegmatis |
2 |
2 |
X-RAY DIFFRACTION |
| 2we9 |
Crystal structure of Rv0371c from Mycobacterium tuberculosis H37Rv |
2 |
2 |
X-RAY DIFFRACTION |
| 2wea |
ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT |
1 |
1 |
X-RAY DIFFRACTION |
| 2web |
ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT |
1 |
1 |
X-RAY DIFFRACTION |
| 2wec |
ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT |
1 |
1 |
X-RAY DIFFRACTION |
| 2wed |
ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT |
1 |
1 |
X-RAY DIFFRACTION |
| 2wee |
Crystal structure of Rv0371c from Mycobacterium tuberculosis H37Rv |
2 |
2 |
X-RAY DIFFRACTION |
| 2wef |
Human 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1) in complex with AMP, PO4 and Magnesium |
1 |
1 |
X-RAY DIFFRACTION |
| 2weg |
Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2weh |
Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2wei |
Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1 |
1 |
1 |
X-RAY DIFFRACTION |
| 2wej |
Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2wek |
Crystal structure of the human MGC45594 gene product in complex with diclofenac |
2 |
2 |
X-RAY DIFFRACTION |
| 2wel |
Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin |
1 |
1 |
X-RAY DIFFRACTION |
| 2weo |
Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors |
1 |
1 |
X-RAY DIFFRACTION |
| 2wep |
Yeast Hsp90 N-terminal domain LI-IV mutant with ADP |
1 |
1 |
X-RAY DIFFRACTION |
| 2weq |
Yeast Hsp90 N-terminal domain LI-IV mutant with Geldanamycin |
1 |
1 |
X-RAY DIFFRACTION |
| 2wer |
Yeast Hsp90 N-terminal domain LI-IV mutant with Radicicol |
2 |
2 |
X-RAY DIFFRACTION |
| 2wes |
Crystal structures of mutant E46Q of tryptophan 5-halogenase (PyrH) |
2 |
2 |
X-RAY DIFFRACTION |
| 2wet |
Crystal structure of tryptophan 5-halogenase (PyrH) complex with FAD (tryptophan) |
2 |
2 |
X-RAY DIFFRACTION |
| 2weu |
Crystal structure of tryptophan 5-halogenase (PyrH) complex with substrate tryptophan |
2 |
2 |
X-RAY DIFFRACTION |
| 2wev |
Truncation and Optimisation of Peptide Inhibitors of CDK2, Cyclin A Through Structure Guided Design |
2 |
2 |
X-RAY DIFFRACTION |
| 2wew |
Crystal structure of human apoM in complex with myristic acid |
1 |
1 |
X-RAY DIFFRACTION |
| 2wex |
Crystal structure of human apoM in complex with glycerol 1- myristic acid |
1 |
1 |
X-RAY DIFFRACTION |
| 2wey |
Human PDE-papaverine complex obtained by ligand soaking of cross- linked protein crystals |
2 |
2 |
X-RAY DIFFRACTION |
| 2wez |
Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1H-indole-6-carboxamide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf0 |
Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-8-(2-oxo-1-pyrrolidinyl)-6-quinolinecarboxamide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf1 |
Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4- dihydro-1H-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2- dioxide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf2 |
Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1H,6H-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf3 |
Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf4 |
Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran-4-ylamino)propyl)-1,3,4,6- tetrahydro(1,2)thiazepino(5,4,3-cd)indole-8-carboxamide 2,2-dioxide |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf5 |
Structure of Beta-Phosphoglucomutase inhibited with Glucose-6-phosphate and trifluoromagnesate |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf6 |
Structure of Beta-Phosphoglucomutase inhibited with Glucose-6-phosphate and Aluminium tetrafluoride |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf7 |
Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphonate and Aluminium tetrafluoride |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf8 |
Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphate, Glucose-1-phosphate and Beryllium trifluoride |
1 |
1 |
X-RAY DIFFRACTION |
| 2wf9 |
Structure of Beta-Phosphoglucomutase inhibited with Glucose-6- phosphate, and Beryllium trifluoride, crystal form 2 |
1 |
1 |
X-RAY DIFFRACTION |
| 2wfa |
Structure of Beta-Phosphoglucomutase inhibited with Beryllium trifluoride, in an open conformation. |
1 |
1 |
X-RAY DIFFRACTION |
| 2wfb |
High resolution structure of the apo form of the orange protein (ORP) from Desulfovibrio gigas |
1 |
1 |
X-RAY DIFFRACTION |
| 2wfc |
Crystal structure of peroxiredoxin 5 from Arenicola Marina |
2 |
2 |
X-RAY DIFFRACTION |
| 2wfd |
Structure of the human cytosolic leucyl-tRNA synthetase editing domain |
1 |
1 |
X-RAY DIFFRACTION |
| 2wfe |
Structure of the Candida albicans cytosolic leucyl-tRNA synthetase editing domain |
4 |
4 |
X-RAY DIFFRACTION |
| 2wff |
Equine Rhinitis A Virus |
1 |
5 |
X-RAY DIFFRACTION |
| 2wfg |
Structure of the Candida albicans cytosolic leucyl-tRNA synthetase editing domain bound to a benzoxaborole-AMP adduct |
1 |
1 |
X-RAY DIFFRACTION |